Researchers at Zhejiang University have developed an intelligent formulation of insulin that could achieve sustained blood sugar-responsive insulin release. After one subcutaneous injection, the formulation formed a pea-sized depot that can remain effective for over a week with negligible hypoglycemia risk.

Source: Zhejiang University